Objective: To determine if the Expanding Maternal and Neonatal Survival (EMAS) program was associated with improved effectiveness of the referral system in Indonesia to facilitate timely and effective management of complications experienced by women and newborns. 
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including health, among the most developed provinces of Java and Bali compared with those on islands further away from the capital. 8 The two most common causes of maternal deaths in Indonesia are hypertensive disorders (pre-eclampsia and eclampsia) and postpartum hemorrhage (PPH), followed by sepsis, obstructed/prolonged labor, and complications of unsafe abortions. 9 Most births in Indonesia are attended by a skilled birth attendant (83%) and the majority (63%) of these births occur in a health facility. 10 Nevertheless, an assessment in five regions in Indonesia found that 41.9% of maternal deaths occurred at public hospitals and that Eastern Indonesia and Sulawesi provinces reported the second highest maternal mortality rates and lower levels of service coverage, compared with Java and Bali. 11 Persistent high maternal morbidity and mortality are likely linked to the lack of health workers' capacity to provide high-quality care, potentially due to insufficient training, limited experience in managing complications, inadequate infrastructure in which care is provided, and geography. 7, 9, 12, 13 Accordingly, efforts have been focused on improving timely access to care, 14, 15 including effective management of complications during labor at community health facilities (puskesmas), and, if necessary, timely and effective referral to a hospital for specialist care. 16 A well-functioning referral system should act as an early warning system for comprehensive emergency obstetric and newborn care (CEmONC) facilities; ideally, ensuring that the necessary staff, supplies, and equipment are fully prepared to provide emergency obstetric and newborn care 24 hours a day, 7 days a week. 16 Previous international studies have identified a number of facility-based factors that slow response times, including ineffective management of complications, a lack of supportive supervision, and unreliable standards of care and monitoring in referral facilities. [17] [18] [19] [20] Overall, a lack of readiness to respond to emergency complications at referring facilities contributes to delays in the provision of care. These factors include inadequate transport, poor communication infrastructure, lack of basic equipment, and inadequate skills and knowledge on the part of providers. 17, 18, 21 In Indonesia, public health care within districts is provided through a network of puskesmas and hospitals. Across the country, PONED (Pelayanan Obstetri dan Neonatal Esensial Dasar) puskesmas are staffed with a physician and several midwives and nurses who are responsible for providing basic emergency obstetric and newborn care (BEmONC), including making detailed plans for how referrals are to be arranged. 22 While the puskesmas network covers a population of 30 000-50 000, many are located in relatively isolated areas with limited infrastructure, variable quality of services, and a lack of PONED capacity. 22, 23 In the event of complications, puskesmas staff should refer clients to hospitals, which should be equipped to provide CEmONC. 22 Previous studies in Indonesia 24,25 identified transport as a major barrier to efficient referral; emergency transport was often unavailable and private transport was unreliable and incurred costs. One study identified patients' and providers' uncertainty about where to seek emergency care, which resulted in patients traveling to several hospitals before receiving treatment, as a source of delay within an ineffective referral system. 12 A reluctance to admit poorer women covered by social health insurance was also found to be the case in some facilities. 13, 24 Other barriers include a lack of proper documentation for health insurance registration, the distance to health facilities, shortage of qualified health workers, overcrowded health facilities, and suboptimal health facility accreditation. 26 Indonesia's highly decentralized health system and a growing private sector, which includes private hospitals and midwives, may also contribute to continuing high maternal morbidity and mortality rates. These may include difficulties in coordination between public and private systems 7,9,27 and a lack of standardized protocols for managing emergency complication and referrals between puskesmas and hospitals. 28 Changes to the health insurance scheme for pregnant mothers may have also influenced service provision and client care-seeking prac- 30 provided in puskesmas and hospitals and in strengthening district-level referral pathways. The EMAS program is fully described in the overview paper published in this Supplement. 31 The purpose of the present study was to determine whether the EMAS program was associated with improved effectiveness of the referral system to facilitate timely and effective management of pregnant women and newborns with complications. We present an analysis of available monitoring data alongside evaluation data to assess outcomes and impact of the EMAS referral interventions, including indicators assessing the effectiveness, efficiency, and timeliness of the referral system to facilitate the management of women and newborns with complications.
| MATERIALS AND METHODS

| Description of the EMAS program and the referral interventions
EMAS was implemented in over 400 hospitals and community health centers (puskesmas) in 30 districts and cities in six provinces in Indonesia: North Sumatra, Banten, West Java, Central Java, East Java, and South Sulawesi. This program was implemented in three phases- evidence-based practices and a formal impact evaluation study was conducted in the last 2 years of the program (2015 and 2016) to assess the two main program objectives related to strengthening the referral system and improving quality of care. 30, 31 The overall objective of the EMAS referral component was to increase the efficiency and effectiveness of referral pathways for emergency complications. The EMAS program employed a districtwide approach to improving the referral system. All facilities (puskesmas and hospitals) in a given district were formally networked to all of the surrounding facilities, including private hospitals. Interventions to maximize the effectiveness of the referral network included:
1. Referral network memoranda of understanding (MOUs) that strengthened linkages and formalized referral networks between BEmONC (puskesmas) and CEmONC (hospital) facilities within a given district. The MOUs also formally integrated private facilities and providers into the district referral system for the first time.
Referral performance standards and tools, adapted from Ministry of
Health guidelines, were introduced along with a comprehensive set of performance monitoring tools and implementation plans. These were augmented with job aids and clinical mentoring sessions.
Performance standards were regularly monitored both at the facility level and at the district level to assess facility-and district-level readiness to manage obstetric and newborn emergencies, identify health system weaknesses, and craft action plans to help address the weaknesses.
3. An automated electronic referral exchange system, SijariEMAS, enabled puskesmas and private midwives to send a two-way message (via phone/call center, SMS, or mobile or web application) to a central server prior to referral that would automatically route that referral to the most appropriate hospital using a pre-specified algorithm per the agreed MOU referral flow. The selected hospital could then choose to accept or reject the referral case depending on their capacity and capabilities at the time. In addition, puskesmas staff could receive messages through the system from the referral hospital about how to stabilize and prepare the patient prior to referral.
| Assessment design
Designing interventions and evaluations that aim to address a multitude of factors that may impact on something as complex as maternal and newborn mortality is challenging. 33 This study aims to assess the outcomes and impact of the EMAS referral interventions utilizing available monitoring and evaluation data to present two separate assessments: (1) A longitudinal analysis to assess the impact of the overall EMAS referral system on improving stabilization practices for emergency complications prior to referral, and identifying facility and geographical characteristics that are associated with improved stabilization practices; and (2) a quasi-experimental analysis to compare improvements in the referral system following the introduction of the electronic automated referral system (SijariEMAS), the primary referral intervention, using evaluation data. These methods are described separately below. period-all were included in this analysis.
Instruments and measures
The MNH monitoring system utilized a standardized set of registers in EMAS facilities, four designed for use in hospitals and three designed for use in puskesmas. Staff at both hospitals and puskesmas routinely entered data into the facility register. The registers were in turn used to complete a summary aggregate form for reporting to the Ministry of Health every month. Data quality and use of these registers was monitored by EMAS program staff, who conducted routine data assessments for completeness and timeliness across all districts and a random quality assurance check each month.
Two indicators from the hospital register that relate to the effectiveness of the referral system were selected for this analysis:
1. Proportion of mothers who were referred to hospital owing to severe pre-eclampsia/eclampsia who received magnesium sulphate (MgSO 4 ) to stabilize their condition before referral.
Proportion of newborns with suspected severe infection who
received an antibiotic before referral.
Information about these two indicators was verified through an accompanying referral letter or information from the midwife who accompanied the mother when referred to a hospital.
Statistical analyses
To estimate the rate of change in the two referral indicators between the start date of EMAS monitoring data (T=0) and end date of EMAS monitoring data (T=1), we used random-effects Poisson regression models where "EMAS exposure period" was the key independent variable and each facility served as its own intercept in the model. As the performance of the facilities was heterogeneous across the six provinces and hospital types by size of hospital beds, delivery volumes, and administration (private and public), the model calculated the difference between T=0 and T=1 by facility, adjusted by hospital facility type (public vs private) and province (West Java, Central Java, East Java, Banten, North Sumatera, and South Sulawesi). Data were analyzed using Stata version 14 (StataCorp LLC, College Station, TX, USA). Results are presented stratified by the three EMAS implementation phases. Significance was set at P<0.05.
One key advantage of this model specification was that the exponentiated beta exp(β) associated with "EMAS exposure period" directly estimated the incidence rate ratio (IRR), which was essentially the rate of change of the indicators (MgSO 4 and antibiotic use).
Overall, this analysis included data from 45 months of exposure for Phase 1, 33 months of exposure for Phase 2, and 21 months for Phase 3; however, the first few months of data collection at the start and at the end of each phase were excluded owing to instability of key maternal mortality indicators (e.g. some health facilities reported unusually high case fatality rates). patients. The study sites, selection, and data collection processes are described in detail in companion articles.
| EMAS evaluation study-assessment of the referral system following the introduction of an electronic automated referral system (SijariEMAS)
Procedures
30,31
Sample A total of 1609 clinical observations, excluding low birth weight cases, were conducted. Referral cases were included in this study if they were considered an "eligible" referral case, defined as any referral that was received at a participating EMAS evaluation study hospital from a puskesmas within the same district and that could be tracked during a specified 4-week observation period. A total of 180 referral cases were included in this analysis.
Instruments and measures
Data collection focused on observations of care provided for women who presented for delivery at each study hospital. Observations were 
Statistical analyses
The evaluation study was designed as a quasi-experimental pre-post assessment, allowing for a difference-in-difference (DID) analysis, comparing changes between EMAS intervention and comparison facilities at baseline (2015) compared with endline (2016). However, the limited number of referral cases captured over the observation period, particular at endline, precluded a DID analysis ( T A total of 3799 newborn referral cases were registered over the study period. Use of antibiotics for treatment of newborns with suspected severe infection prior to referral was quite low at (30%)
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at the start the EMAS project (Fig. 2) . Use almost doubled to 54%
(IRR 2.0; 95% CI, 1.6-2.4) during the EMAS intervention period.
In EMAS Phase 1, antibiotic use increased significantly from 32%
to 66%, and almost three-fold in Phase 2 sites (from 20% to 59%). 95% CI, 1.3-10.6) ( Table 1) .
| EMAS evaluation study
Among all cases of obstetric complications (n=434) whose management was directly observed in hospitals, a total of 180 eligible pregnant women who were referred to hospitals were included in this analysis ( Table 2 ). The total number of clinical observations in both comparison and intervention arms declined between baseline and endline time points, particularly for cases without obstetric or newborn complications. In contrast, the number of obstetric or newborn complications increased or remained stable over the same period in both arms. However, the number of referral cases that were eligible and captured at endline diverged between arms, declining between baseline and endline in the comparison arms, and increasing or holding stable between baseline and endline in the EMAS intervention arm.
Interestingly, East Java province reported no referrals at endline in both comparison and EMAS intervention districts. In total, 71 (39.5%) pregnant women were referred through SijariEMAS compared with 109 (60.5%) referrals that did not use SijariEMAS (standard of care) ( Table 2 ).
Of obstetric referral cases, among facilities using SijariEMAS, a significantly higher proportion were severe pre-eclampsia/eclampsia cases (83.1%) compared with those that did not use SijariEMAS (62.4%). Conversely, a significantly lower proportion of cases were
PPH (16.9%) at facilities using SijariEMAS compared with those that did not (32.1%). No maternal sepsis and newborn referral cases
were referred using SijariEMAS (Table 3 ). All cases were referred to public hospitals. PONED puskesmas had significantly higher proportions of referral cases using SijariEMAS, but there was no significant difference for non-PONED puskesmas. No differences were seen by province in the proportion of referral cases both using or not using SijariEMAS, except in East Java where no referral cases were reported in intervention districts. The most common reasons for a puskesmas to refer a case included "service required was not appropriate to be delivered at the puskesmas (e.g. cesarean delivery)," "no equipment to manage complication," "no staff with the clinical skills/capacity to manage complication," and "not enough staff to manage complication." These were similar across cases that did and did not use SijariEMAS, except for a higher proportion of cases that reported "not enough staff to manage complication" used SijariEMAS (P<0.01) and a higher proportion of cases that reported "no staff with the clinical skills or capacity to manage complication" did not use SijariEMAS. Referral outcomes were similar across cases that did and did not use SijariEMAS.
| Referral effectiveness
When pregnant women were referred using SijariEMAS, there were consistently higher levels of effective communication (P<0.01) and advanced notification (P<0.01) between the puskesmas and hospital compared with pregnant women who were referred without using SijariEMAS (Table 4) . Pregnant women who were referred using SijariEMAS were also more likely to have been transported to the hospital in ambulance, accompanied by a health worker, had their health insurance checked prior to referral, and had a referral slip. SijariEMAS also provided a mechanism to support information exchange back to the puskesmas following treatment at the hospital, with significantly higher levels of information provided about diagnosis sent back to the puskesmas. Cases referred using SijariEMAS had consistently higher levels of stabilization for pre-eclampsia/eclampsia prior to referral to the hospital, with limited improvement to the appropriate stabilization of PPH cases, and higher levels of hospital readiness, including proportions of hospital emergency staff coordination, supplies/equipment arranged on a trolley, and emergency staff roles clearly designated and in preparation to receive the referral (Table 4) .
| Referral efficiency
The time that puskesmas staff took between when the decision was made to refer a pregnant woman to when she actually departed the puskesmas was similar among cases that used SijariEMAS compared with those that did not use SijariEMAS (approximately 30 minutes each, P=0.32) (Table 5 ). However, the elapsed time between the woman leaving the puskesmas and arriving at hospital was slightly shorter among cases that used SijariEMAS compared with those that did not (75 minutes vs 60 minutes), although this was not significant (P=0.36). the EMAS program to monitor and track progress, which did not include any control sites, our ability to attribute changes in stabilization practices directly to the EMAS program is limited. While it is possible that improvements in stabilization practices seen in this study may have been due to other possible factors outside of EMAS interventions, such as changes in the health insurance scheme JKN, consistency in the effects seen in stabilization practices for both obstetric and newborn complications during all three phases, from The quasi-experimental pre-post assessment of the referral system following the introduction of SijariEMAS system, provided evidence for the utility and impact of an electronic automated referral system to improve both the effectiveness and efficiency of the referral system and also the overall referral-related EMAS interventions, including the district-wide referral MOU. SijariEMAS appeared to be beneficial for the effective transfer of pregnant women in need of referral by providing an actionable information system that links puskesmas and hospitals. This enabled staff to appropriately stabilize, prepare, and transport pregnant women to a referral hospital and, at the same time, allow the referral hospital to appropriately prepare and coordinate activities prior to the arrival of the pregnant woman.
| DISCUSSION
The evaluation data clearly highlighted an overall decline in the total number of cases observed at hospitals between baseline and endline time points, yet a stable or increased proportion of complications being managed at the hospitals (Table 2 ). This pattern may be indicative of more efficient management of noncomplicated cases at the puskesmas level and better decision making about referring only complicated cases to hospitals to alleviate overcrowding. 22 This in line with national health insurance scheme JKN polices, which mandate that all pregnant mothers requiring a referral must first present at a puskesmas to receive a referral slip prior to attending a hospital within the same district. 23 The high numbers of referral cases that were observed in the EMAS intervention arm compared with the comparison arm at T A B L E 4 Referral effectiveness outcomes among referral cases that used SijariEMAS compared with referral cases that did not use SijariEMAS (n=175, obstetric cases only). endline (Table 2) , supports the impact of the overall EMAS program on improving the efficiency and effectiveness of the referral system to facilitate timely and effective management of complications experienced by women. These findings also highlight the unique challenges with designing evaluations for complex and large-scale intervention studies in real-world settings, but these challenges do not diminish the findings, as this analysis was focused on the management of complications, and the numbers of complications remained stable or increased over time within the EMAS interventions sites.
There was limited evidence for the impact of SijariEMAS on improving the timeliness of the referral, with significant variations in response times from when the decision was made to refer the pregnant women in need to time of departure from the puskesmas, and the time between leaving the puskesmas and arriving at the hospital. Reducing delays in pregnant women receiving CEmONC is critical in reducing risks, but ensuring effective stabilization of complications prior to referral is also key. 22 One potential explanation for these findings is that facilities that used SijariEMAS were also more likely to appropriately stabilize pregnant mothers with pre-eclampsia/eclampsia with MgS0 4 or provide antibiotics to newborns with suspected severe infection prior to referral compared with cases that did not use SijariEMAS, which may have subsequently increased their response times. These additional processes for preparing a patient for referral may take longer, but could arguably result in better quality of care and appropriate management of emergency complications overall. Response times between the pregnant women departing the puskesmas and arriving at the hospital may also be dependent on factors not captured in this evaluation, including variation in distances between puskesmas and hospitals.
A systematic review of emergency obstetric referral interventions in low-resource settings identified similar challenges in addressing the delays in referral pathways for obstetric and immediate newborn care. 25 The review highlighted that while transport and communication interventions were becoming more popular and evidence is building for their effectiveness, it is difficult to measure the impact of referral interventions, which often included multiple interventions designed to reduce delays at several stages of the referral process. These factors make it hard to disentangle the contribution of each component of the intervention.
A recent study in Bangladesh, 34 also highlighted that important factors in a successful referral included early detection of complications experienced by mothers, quality support by a midwife, and quick transfer to the referral center. Our study findings were consistent with these findings and provide further evidence for the utility of an automated electronic communication system to serve as an assist in the timely referral and management of obstetric and newborn complications along with the overall positive impact of the EMAS-related referral interventions.
| Limitations
We recognize that our study has a few limitations. We utilized data from the MNH data monitoring system that was set up by the EMAS The timing of the evaluation study allowed us only to include data from Phase 3 intervention districts in this analysis. This is likely to attenuate the EMAS effectiveness, which shows the EMAS effect for 1 year only, rather for 5-years-the total program period. The small number of overall referral cases tracked within the evaluation study prevented complication-specific referral and case-management analyses.
| CONCLUSION
Notwithstanding the limitations, we believe that the findings from this study indicate that the EMAS program contributed to improvements in the overall management of emergency obstetric and newborn complications at different points along the referral pathway. The use of SijariEMAS, in combination with other referral interventions, was associated with enhanced communication, transportation, and preparation of pregnant mothers in need of referral, and also increased the hospital emergency readiness and staff preparedness to effectively manage obstetric and newborn complications. These steps should help to reduce the delays in access to care for pregnant women and newborns with complications and reduce the high levels of maternal mortality across Indonesia-a key aim of the EMAS program.
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